Document Detail


Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants.
MedLine Citation:
PMID:  641216     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Indomethacin failed to produce permanent ductal closure in any of four premature infants with patent ductus arteriosus to whom the drug was given. Indomethacin half-lives measured in two premature infants were 21 and 24 hours, respectively, much longer than in full-term newborns or adults. Platelet function, as measured by platelet aggregation, was grossly abnormal for two to four days after indomethacin administration, normal values returning only by the ninth and tenth days. Gastrointestinal bleeding and transient renal dysfunction occurred in one infant. Measurement of plasma indomethacin concentrations in sick, low-birthweight infants could help guide indomethacin dose and dosage interval, prevent drug accumulation, and reduce toxicity. Further studies of potential toxicity seem to be indicated before instituting widespread indomethacin administration for ductal closure in premature infants.
Authors:
Z Friedman; V Whitman; M J Maisels; W Berman; K H Marks; E S Vesell
Related Documents :
7351906 - Effect of fluid administration on the development of symptomatic patent ductus arterios...
16779846 - Diameter of paediatric sized flexible bronchoscopes: when size matters.
17203336 - Usefulness of indomethacin for patent ductus arteriosus in full-term infants.
19187396 - Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus.
14730156 - 24-hour electrocardiogram before and during cisapride treatment in neonates and infants.
23556466 - Early prenatal food supplementation ameliorates the negative association of maternal st...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of clinical pharmacology     Volume:  18     ISSN:  0091-2700     ISO Abbreviation:  J Clin Pharmacol     Publication Date:    1978 May-Jun
Date Detail:
Created Date:  1978-06-17     Completed Date:  1978-06-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0366372     Medline TA:  J Clin Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  272-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Platelet Disorders / blood,  chemically induced*
Blood Proteins / metabolism
Ductus Arteriosus, Patent / blood,  drug therapy*
Female
Half-Life
Humans
Indomethacin / adverse effects,  blood*,  therapeutic use
Infant, Newborn*
Infant, Newborn, Diseases / blood,  chemically induced*
Male
Platelet Aggregation / drug effects
Protein Binding
Time Factors
Chemical
Reg. No./Substance:
0/Blood Proteins; 53-86-1/Indomethacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rapid estimation of volume of distribution after a short intravenous infusion and its application to...
Next Document:  A cytologic study of Grandry corpuscle development in chicken toe skin.